share_log

Jefferies Downgrades Usana Health Sciences to Underperform, Lowers Price Target to $53

Benzinga Real-time News ·  Jul 7, 2022 12:08

Jefferies analyst Stephanie Wissink downgrades Usana Health Sciences (NYSE:USNA) from Hold to Underperform and lowers the price target from $78 to $53.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment